Mather Group’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21K Buy
419
+3
+0.7% +$59 ﹤0.01% 1520
2026
Q1
$7.4K Buy
+416
New +$7.87K ﹤0.01% 1518
2025
Q4
Sell
-416
Closed -$7.68K 1079
2025
Q3
$7.68K Buy
+416
New +$6.79K ﹤0.01% 1313
2025
Q2
Sell
-416
Closed -$6.76K 1093
2025
Q1
$6.76K Hold
416
﹤0.01% 1346
2024
Q4
$6.68K Hold
416
﹤0.01% 1327
2024
Q3
$7.75K Hold
416
﹤0.01% 1216
2024
Q2
$7.01K Hold
416
﹤0.01% 1538
2024
Q1
$6.89K Buy
+416
New +$7.09K ﹤0.01% 1286

Other funds holding HQH

Mather Group's HQH Position: Q2 2026 in Review

Mather Group increased its abrdn Healthcare Investors (HQH) stake by 0.72% in Q2 2026, buying an estimated $59 and bringing the position to 419 shares worth $9.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Mather Group first reported a position in HQH in Q1 2024 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Mather Group held 419 shares of abrdn Healthcare Investors worth $9.21K as of Q2 2026.
  • Mather Group bought 3 abrdn Healthcare Investors shares in Q2 2026, an estimated $59.
  • abrdn Healthcare Investors made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1520 holding.
  • Mather Group first reported a position in abrdn Healthcare Investors in Q1 2024 and has held it in 8 quarters since.
  • 126 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.